ArticleBiomedical optics express2025
Simulation-based dosimetry of transcranial and intranasal photobiomodulation of the human brain: the roles of wavelength, power density, and skin tone.
Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- [A simulation study of photothermal effects in transcranial photobiomodulation].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026Article
- Dose dependence and neurovascular mechanisms of the fMRI response to pulsed photobiomodulation in humans.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026Article
- Application of non-invasive transcranial photobiomodulation in ischemic stroke: Mechanisms and current insights.iScience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Photobiomodulation (PBM) using near-infrared (NIR) light is a novel neuromodulation technique. However, despite the many in vivo studies, the stimulation protocols for PBM vary across studies, and the current understanding of the physiological effects of PBM, as well as the dose dependence, is limited. Specifically, although NIR light can be absorbed by melanin in the skin, the understanding of how skin tones compare and how their influence interacts with other dose parameters remains limited. This study investigates the effect of melanin, optical power density, and wavelength on light penetration and energy accumulation via forehead and intranasal PBM. We use Monte Carlo simulations of a single laser source for transcranial (tPBM, forehead position) and intranasal (iPBM, nostril position) irradiation on a healthy human brain model. We investigate wavelengths of 670, 810, and 1064 nm at various power densities in combination with light ("Caucasian"), medium ("Asian"), and dark ("African") skin tone categories as defined in the literature. Our simulations show that a maximum of 15% of the incidental energy for tPBM and 1% for iPBM reaches the cortex from the light source. The rostral dorsal prefrontal cortex and the ventromedial prefrontal cortex accumulate the highest light energy in tPBM and iPBM, respectively, for both wavelengths. Notably, we show that nominally "Caucasian" skin allows the highest energy accumulation of all three skin tones. Moreover, the 810 nm wavelength for tPBM and the 1064 nm wavelength for iPBM produced the highest cortical energy accumulation, which was linearly correlated with optical power density, but these variations could be overridden by a difference in skin tone in the tPBM case.The simulations serve as a starting point for enabling hypothesis generation for in vivo PBM investigations. This study is the first to account for skin tone as a tPBM dosing consideration. For the future of PBM research, it is important to evaluate combinations of stimulation parameters (wavelength, optical power density, pulsation frequency, duration, light source) when working to determine an optimal dosage for PBM-based therapy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.